Company Performance Metrics
Quodria is a biotechnology company that develops pharmaceutical and skincare therapies for dermatological conditions. It focuses on research and development of next-generation topical treatments for chronic skin diseases and common dermatological disorders. The company applies expertise in nanotechnology, drug development, and nano-formulations to
create both over-the-counter and prescription skin health products. Its development approach follows Quality by Design principles, integrating pharmaceutical development, clinical considerations, and regulatory requirements from early research stages. Quodria maintains an internal pipeline of candidates, including Q001, a topical therapy under development for the management of atopic dermatitis. It also collaborates with external partners to advance novel drug candidates based on academic and industry research.
